Last Updated: April 18, 2017
Filed under:
Print Friendly, PDF & Email

Specialty Pharmacy Times: The health care world is largely moving towards a focus on value, rather than paying a pre-specified cost for prescription drugs that may or may not successfully treat a specific patient. This shift has important implications for manufacturers, (more…)

Last Updated: April 19, 2017
Filed under:
Print Friendly, PDF & Email

Specialty Pharmacy Times: Specialty drugs require increased monitoring and education provided by various health care professionals. More than ever, pharmacists are being included in innovative care teams to improve patient outcomes, especially when it comes to disease states, such as cancer. (more…)

Last Updated: April 3, 2017
Filed under:
Print Friendly, PDF & Email

PR NewsWire: Janssen Pharmaceuticals, Inc. today announced it has collaborated with Premier Inc. on the first and largest study of its kind to address an unmet medical need for hospitalized patients with atrial fibrillation (AF) who are at risk for ischemic (more…)

Last Updated: December 12, 2016
Filed under:
Print Friendly, PDF & Email

By Michael J. Alkire, COO of Premier Members of the Premier alliance commend the solicitor general for recommending the Supreme Court hear the case of Sandoz v. Amgen. This landmark case could overturn a lower court decision requiring biosimilar manufacturers (more…)

Last Updated: October 28, 2016
Filed under:
Print Friendly, PDF & Email

HealthcareDive: Over the past couple of years, Dr. Bimal Shah has seen dozens of value-based drug pricing contract negotiations falter. As vice president for the research division of Premier, a provider-owned healthcare improvement company, he oversees research to identify opportunities for (more…)